Four reasons to use digital health in your clinical trials

In the first of our digital health series we will outline what the term means, and the opportunities offered, within the context of clinical trials in psychiatry. 

New client signs with Cognition Kit software

We’re delighted to announce a new $0.5m contract with a major pharmaceutical company for the use of our Cognition Kit digital health software in a clinical trial.

Cognition Kit wearable technology demonstrates high compliance among patients with major depressive

​At the 2017 International CNS Summit in Boca Raton, Florida, we were pleased to release the positive results from a pilot study into the evaluation of cognition and mood using wearable technology in patients with MDD.

Join us at the CNS Summit 2017

Cambridge Cognition are attending the Collaborating for Novel Solutions (CNS) Summit: 16th-19th November 2017. 

Feasibility of automated voice based cognitive assessment on a consumer voice platform

Exploring the use of automated voice based cognitive assessments on consumer voice platforms.

What is test-retest reliability and why is it important?

Digital Health & Innovation Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests.